홈 › 만성 폐쇄성 폐질환 › 앨라배마 › Birmingham
AL Birmingham의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 18개가 Birmingham 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
피험자 모집 중2상
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
피험자 모집 중4상
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
피험자 모집 중3상
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
피험자 모집 중2상
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
피험자 모집 중2상
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
피험자 모집 중1상
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
피험자 모집 중2/3상
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
피험자 모집 중3상
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
피험자 모집 중관찰 연구
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
피험자 모집 중3상
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
피험자 모집 중
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
피험자 모집 중관찰 연구건강한 지원자 환영
- University of Alabama at Birmingham, Birmingham
Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
피험자 모집 중2상
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
피험자 모집 중
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
피험자 모집 중
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
피험자 모집 중관찰 연구
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
피험자 모집 중4상
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
피험자 모집 중
- UAB School of Medicine/Lung Health Center, Birmingham
다른 도시의 만성 폐쇄성 폐질환 시험
- Philadelphia, PA연구 22개
- Miami, FL연구 18개
- Boston, MA연구 17개
- Houston, TX연구 15개
- Orlando, FL연구 15개
- Chicago, IL연구 14개
- Pittsburgh, PA연구 13개
- Baltimore, MD연구 13개
- Dallas, TX연구 12개
- New York City, NY연구 11개
- Ann Arbor, MI연구 10개
- Phoenix, AZ연구 9개
Birmingham의 다른 연구
- 암 (전체)연구 31개
- 유방암연구 24개
- 비만연구 24개
- 난소암연구 23개
- 비소세포폐암연구 22개
- 급성 골수성 백혈병연구 21개
- 다발성 골수종연구 18개
- 과체중연구 17개
- 심혈관 질환연구 17개
- 제2형 당뇨병연구 16개
- 자궁내막암연구 16개
- 낭성 섬유증연구 16개
ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.